Richard Klausner - Director at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

Richard Klausner - trading volume in the past year for Lyell Immunopharma, Inc.

Holdings reported by Richard Klausner for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,967,834 $1,394,881 $0.4700 15 May 2025 Direct
Common Stock 843,365 $396,381 $0.4700 15 May 2025 Grantor and Trustee
Option (right to buy) 130,000 15 May 2025 Direct Common Stock
Option (right to buy) 130,000 14 Jun 2024 Direct Common Stock

Transactions reported by Richard Klausner for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.